This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.86% per year. These returns cover a period from January 1, 1988 through September 7, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
Zacks News
Markets Brave Coronavirus Second Wave: 5 Best ETFs of Last Week
by Sanghamitra Saha
Last week was moderate for the Wall Street despite rising coronavirus cases.
Today's Quadruple Witching Could Accentuate Volatility
by Daniel Laboe
I think the markets have some room for a pullback at these seemingly frothy levels
U.S. Account Deficit Improves in Q1 to -$104.2 Billion
by Mark Vickery
We have seen our deficit come down steadily over the past 4 quarters, but initiatives to thwart the coronavirus pandemic may bring us a new trajectory in Q2.
5 Niche Tech ETFs That Have Gained More Than 30% in 1H
by Sweta Killa
Most of the rally has been driven by the e-commerce boom and the shift in consumer habits to a purely digital world.
Jobless Claims Lower??? But Plateauing?
by Mark Vickery
Between May 17th and 24th we were down 15% on new claims. From last week to this, we're 4% lower on new jobless claims.
Housing Starts' Sluggish Rebound, Powell Concludes Today
by Mark Vickery
The disappointment on new Housing Starts comes from what had been perceived as excessive pent-up demand, especially single-family housing.
Resurgence In Retail Sales
by Daniel Laboe
Consumers' retail spending spiked 18% in May from the prior month, the largest monthly increase since 1992
Should Goldman Sachs Equal Weight U.S. Large Cap Equity ETF (GSEW) Be on Your Investing Radar?
by Sweta Killa
Style Box ETF report for GSEW
Oxford Discovers COVID-19 Treatment, Plus Record Retail Sales
by Mark Vickery
Dexamethasone is a generic anti-inflammatory drug already prescribed by physicians more than a million times per year, for various conditions.
Zacks Told You to "Buy the Dips." Did You?
by Mark Vickery
A new announcement from the Fed rekindled the market's buying appetite today, with a new bond-purchasing program up to $750 billion.